Suzanne T. Ildstad's most recent trade in Talaris Therapeutics Inc was a trade of 75,001 Common Stock done at an average price of $2.4 . Disclosure was reported to the exchange on June 7, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.39 per share. | 07 Jun 2023 | 75,001 | 3,881,473 | - | 2.4 | 179,095 | Common Stock |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.48 per share. | 07 Jun 2023 | 40,642 | 3,840,831 | - | 2.5 | 100,772 | Common Stock |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.46 per share. | 07 Jun 2023 | 25,419 | 3,815,412 | - | 2.5 | 62,637 | Common Stock |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.53 per share. | 05 Jun 2023 | 25,549 | 2,756,474 | - | 2.5 | 64,596 | Common Stock |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.52 per share. | 05 Jun 2023 | 7,841 | 2,782,023 | - | 2.5 | 19,755 | Common Stock |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 01 Jun 2023 | 15,818 | 2,789,864 | - | 2.5 | 39,616 | Common Stock |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.56 per share. | 01 Jun 2023 | 15,713 | 2,805,682 | - | 2.6 | 40,177 | Common Stock |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.35 per share. | 21 Apr 2023 | 15,004 | 2,821,395 | - | 2.3 | 35,231 | Common Stock |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.33 per share. | 19 Apr 2023 | 46,990 | 2,836,399 | - | 2.3 | 109,313 | Common Stock |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.16 per share. | 19 Apr 2023 | 21,753 | 2,883,389 | - | 2.2 | 47,056 | Common Stock |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.14 per share. | 17 Apr 2023 | 99,771 | 2,954,353 | - | 2.1 | 213,530 | Common Stock |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.15 per share. | 17 Apr 2023 | 49,211 | 2,905,142 | - | 2.2 | 105,804 | Common Stock |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.06 per share. | 17 Mar 2023 | 10,436 | 3,054,124 | - | 2.1 | 21,543 | Common Stock |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.06 per share. | 03 Mar 2023 | 6,806 | 3,064,560 | - | 2.1 | 13,992 | Common Stock |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.03 per share. | 01 Mar 2023 | 29 | 3,071,366 | - | 2.0 | 59 | Common Stock |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.05 per share. | 21 Feb 2023 | 3,500 | 3,071,395 | - | 2.1 | 7,185 | Common Stock |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.05 per share. | 16 Feb 2023 | 3,612 | 3,074,895 | - | 2.1 | 7,406 | Common Stock |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.06 per share. | 16 Feb 2023 | 2,939 | 3,078,507 | - | 2.1 | 6,040 | Common Stock |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 2.80 per share. | 22 Aug 2022 | 525,000 | 3,081,446 | - | 2.8 | 1,470,000 | Common Stock |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Feb 2022 | 1,200,000 | 3,606,446 | - | 0 | Common Stock | |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Feb 2022 | 1,200,000 | 1,200,000 | - | 0 | Common Stock | |
| Talaris Therapeutics Inc | Suzanne T. Ildstad | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) |